zffoto / Shutterstock
Competitive intelligence and technology consulting firm Cipher has hired Dawn Faint, former Market Insights Manager for global health services organization Cigna, as director of Life Sciences.
Faint will lead the development of healthcare-focused initiatives at Cipher, including the expansion of the Life Sciences module in Cipher's Knowledge360® software solution.
"Dawn has been a valued client of ours for years, and as she steps away from her internal corporate role at Cigna we are thrilled that she has chosen Cipher for the next phase of her career. She brings to our team extensive experience in several different aspects of the life sciences industry, and she will be a tremendous asset to our clients in the biotech, pharma, and medical device spaces," said Peter Grimm, Managing Director of Cipher.
Dawn's past experience includes leadership roles at Cigna, Schering-Plough, Pharmacia (now Pfizer) and Johnson & Johnson companies Ortho Biotech and Ortho-McNeil, and in the Management Consulting space for Right Management. Ms. Faint specializes in research, competitive intelligence, marketing and business development.
"I'm excited to join the Cipher team in support of their life sciences clients. The dedication of this team to the long and short-term success of their clients is unparalleled," said Faint. "As a former client, I know the true value of Cipher's innovative tools such as Knowledge360® and their expert competitive and market intelligence consulting services."
Cipher, Dawn Faint, Appointment, Cigna, North America
